Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in ZYME — Zymeworks Inc.

CIK 1390777 NEW YORK, NY
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,427,109
+$319,522 QoQ
Shares Held
131,106
+5.6% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 202 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 89% Shared 0% None 11%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ZYME ranks #119 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in ZYME

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,427,109 131,106
2026-03-31 $3,107,587 124,105
2025-12-31 $3,373,686 128,131
2025-09-30 $2,349,387 137,552
2025-06-30 $1,670,279 133,090
2025-03-31 $1,437,857 120,727
2024-12-31 $1,766,798 120,683
2024-09-30 $3,137,386 249,991
2024-06-30 $2,635,572 309,703
2024-03-31 $3,102,116 294,878
2023-12-31 $2,876,979 276,899
2023-09-30 $883,889 139,415
2023-06-30 $1,184,542 137,100